{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:51:23Z","timestamp":1790175083203,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["2013\/472"],"award-info":[{"award-number":["2013\/472"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1124210"],"award-info":[{"award-number":["1124210"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5846-3","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T14:03:08Z","timestamp":1561125788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-1479","authenticated-orcid":false,"given":"Kerri","family":"Beckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Josephs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Garmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Haggstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Van Hemelrijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Adolfsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"5846_CR1","unstructured":"Shacter E, Weitzman SA: Chronic inflammation and cancer. Oncology (Williston Park) 2002, 16(2):217\u2013226, 229; discussion 230-212."},{"issue":"1","key":"5846_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","volume":"60","author":"KS Sfanos","year":"2012","unstructured":"Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology. 2012;60(1):199\u2013215.","journal-title":"Histopathology"},{"issue":"5","key":"5846_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2217\/14796694.4.5.637","volume":"4","author":"S Vasto","year":"2008","unstructured":"Vasto S, Carruba G, Candore G, Italiano E, Di Bona D, Caruso C. Inflammation and prostate cancer. Future Oncol. 2008;4(5):637\u201345.","journal-title":"Future Oncol"},{"issue":"3","key":"5846_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.urolonc.2006.09.014","volume":"25","author":"S Sutcliffe","year":"2007","unstructured":"Sutcliffe S, Platz EA. Inflammation in the etiology of prostate cancer: an epidemiologic perspective. Urol Oncol. 2007;25(3):242\u20139.","journal-title":"Urol Oncol"},{"key":"5846_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-0348-0837-8_7","volume":"816","author":"KS Sfanos","year":"2014","unstructured":"Sfanos KS, Hempel HA, De Marzo AM. The role of inflammation in prostate cancer. Adv Exp Med Biol. 2014;816:153\u201381.","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"5846_CR6","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/ijc.31256","volume":"142","author":"R Arthur","year":"2018","unstructured":"Arthur R, Williams R, Garmo H, Holmberg L, Stattin P, Malmstrom H, Lambe M, Hammar N, Walldius G, Robinsson D, et al. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study. Int J Cancer. 2018;142(11):2254\u201362.","journal-title":"Int J Cancer"},{"issue":"3","key":"5846_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ijc.21883","volume":"119","author":"H Wang","year":"2006","unstructured":"Wang H, Rothenbacher D, Low M, Stegmaier C, Brenner H, Diepgen TL. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer. 2006;119(3):695\u2013701.","journal-title":"Int J Cancer"},{"issue":"7","key":"5846_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/aje\/kwg020","volume":"157","author":"A Talbot-Smith","year":"2003","unstructured":"Talbot-Smith A, Fritschi L, Divitini ML, Mallon DF, Knuiman MW. Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol. 2003;157(7):606\u201312.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"5846_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/ijc.23666","volume":"123","author":"K Hemminki","year":"2008","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K. Cancer risks in ulcerative colitis patients. Int J Cancer. 2008;123(6):1417\u201321.","journal-title":"Int J Cancer"},{"issue":"3","key":"5846_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/annonc\/mdn595","volume":"20","author":"K Hemminki","year":"2009","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K. Cancer risks in Crohn disease patients. Ann Oncol. 2009;20(3):574\u201380.","journal-title":"Ann Oncol"},{"issue":"6","key":"5846_CR11","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/rheumatology\/keq040","volume":"49","author":"J Ji","year":"2010","unstructured":"Ji J, Liu X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology (Oxford). 2010;49(6):1158\u201363.","journal-title":"Rheumatology (Oxford)"},{"issue":"4S","key":"5846_CR12","first-page":"e135","volume":"189","author":"Z Klaassen","year":"2013","unstructured":"Klaassen Z, Tatem A, Augusta G, Patil S, Livingston N, Madi R, Terris M, Moses K. Prostate cancer incidence in patients with autoimmune diseases: a population-based analysis (conference abstract). J Urol. 2013;189(4S (Suppl):e135.","journal-title":"J Urol"},{"issue":"2","key":"5846_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/pds.1163","volume":"15","author":"A Gonzalez-Perez","year":"2006","unstructured":"Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia Rodriguez LA. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf. 2006;15(2):131\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"5846_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/ijc.29463","volume":"137","author":"EA Platz","year":"2015","unstructured":"Platz EA, Drake CG, Wilson KM, Sutcliffe S, Kenfield SA, Mucci LA, Stampfer MJ, Willett WC, Camargo CA Jr, Giovannucci E. Asthma and risk of lethal prostate cancer in the health professionals follow-up study. Int J Cancer. 2015;137(4):949\u201358.","journal-title":"Int J Cancer"},{"issue":"1","key":"5846_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/oxfordjournals.aje.a114087","volume":"122","author":"JE Vena","year":"1985","unstructured":"Vena JE, Bona JR, Byers TE, Middleton E Jr, Swanson MK, Graham S. Allergy-related diseases and cancer: an inverse association. Am J Epidemiol. 1985;122(1):66\u201374.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"5846_CR16","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1002\/ijc.25956","volume":"129","author":"S Bernatsky","year":"2011","unstructured":"Bernatsky S, Ramsey-Goldman R, Gordon C, Clarke AE. Prostate cancer in systemic lupus erythematosus. Int J Cancer. 2011;129(12):2966\u20139.","journal-title":"Int J Cancer"},{"issue":"6","key":"5846_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s10552-009-9298-y","volume":"20","author":"A Parikh-Patel","year":"2009","unstructured":"Parikh-Patel A, White RH, Allen M, Cress R. Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control. 2009;20(6):1001\u201310.","journal-title":"Cancer Causes Control"},{"key":"5846_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1741-7015-12-55","volume":"12","author":"Y Liu","year":"2014","unstructured":"Liu Y, Chen JQ, Xie L, Wang J, Li T, He Y, Gao Y, Qin X, Li S. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis. BMC Med. 2014;12:55.","journal-title":"BMC Med"},{"issue":"6","key":"5846_CR19","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/ijc.25465","volume":"128","author":"AS Murad","year":"2011","unstructured":"Murad AS, Down L, Davey Smith G, Donovan JL, Athene Lane J, Hamdy FC, Neal DE, Martin RM. Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study). Int J Cancer. 2011;128(6):1442\u20138.","journal-title":"Int J Cancer"},{"key":"5846_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1477-7819-12-304","volume":"12","author":"X Wang","year":"2014","unstructured":"Wang X, Lin YW, Wu J, Zhu Y, Xu XL, Xu X, Liang Z, Hu ZH, Li SQ, Zheng XY, et al. Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk. World J Surg Oncol. 2014;12:304.","journal-title":"World J Surg Oncol"},{"issue":"9","key":"5846_CR21","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1158\/1055-9965.EPI-10-0381","volume":"19","author":"G Severi","year":"2010","unstructured":"Severi G, Baglietto L, Muller DC, English DR, Jenkins MA, Abramson MJ, Douglass JA, Hopper JL, Giles GG. Asthma, asthma medications, and prostate cancer risk. Cancer Epidemiol Biomark Prev. 2010;19(9):2318\u201324.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"5846_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0090-4295(02)01637-0","volume":"60","author":"LK Dennis","year":"2002","unstructured":"Dennis LK, Lynch CF, Torner JC. Epidemiologic association between prostatitis and prostate cancer. Urology. 2002;60(1):78\u201383.","journal-title":"Urology"},{"issue":"4","key":"5846_CR23","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/ije\/dys068","volume":"42","author":"M Van Hemelrijck","year":"2013","unstructured":"Van Hemelrijck M, Wigertz A, Sandin F, Garmo H, Hellstrom K, Fransson P, Widmark A, Lambe M, Adolfsson J, Varenhorst E, et al. Cohort profile: the National Prostate Cancer Register of Sweden and prostate Cancer data base Sweden 2.0. Int J Epidemiol. 2013;42(4):956\u201367.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"5846_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"key":"5846_CR25","unstructured":"National working group for cancer care: National Prostate Care Program. In.: Regional Cancer Centre Uppsala, Orebro; 2015."},{"issue":"3","key":"5846_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.eururo.2012.10.001","volume":"63","author":"T Nordstrom","year":"2013","unstructured":"Nordstrom T, Aly M, Clements MS, Weibull CE, Adolfsson J, Gronberg H. Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: results from a population-based study, 2003-2011. Eur Urol. 2013;63(3):419\u201325.","journal-title":"Eur Urol"},{"issue":"6","key":"5846_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/00365599.2010.498793","volume":"44","author":"O Bratt","year":"2010","unstructured":"Bratt O, Berglund A, Adolfsson J, Johansson JE, Tornblom M, Stattin P, Steering Committee of the Swedish National Prostate Cancer R. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden. Scand J Urol Nephrol. 2010;44(6):384\u201390.","journal-title":"Scand J Urol Nephrol"},{"issue":"8","key":"5846_CR28","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3109\/0284186X.2012.762998","volume":"52","author":"A Hayat Roshanai","year":"2013","unstructured":"Hayat Roshanai A, Nordin K, Berglund G. Factors influencing primary care physicians\u2019 decision to order prostate-specific antigen (PSA) test for men without prostate cancer. Acta Oncol. 2013;52(8):1602\u20138.","journal-title":"Acta Oncol"},{"issue":"10","key":"5846_CR29","doi-asserted-by":"publisher","first-page":"424 e421","DOI":"10.1016\/j.urolonc.2015.06.013","volume":"33","author":"D Pucheril","year":"2015","unstructured":"Pucheril D, Dalela D, Sammon J, Sood A, Sun M, Trinh QD, Menon M, Abdollah F. The influence of physician recommendation on prostate-specific antigen screening. Urol Oncol. 2015;33(10):424 e421\u20137.","journal-title":"Urol Oncol"},{"issue":"12","key":"5846_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/MLR.0b013e318269e096","volume":"50","author":"AA Kotwal","year":"2012","unstructured":"Kotwal AA, Schumm P, Mohile SG, Dale W. The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample. Med Care. 2012;50(12):1037\u201344.","journal-title":"Med Care"},{"issue":"6","key":"5846_CR31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","volume":"47","author":"S Bonovas","year":"2004","unstructured":"Bonovas S, Filioussi K, Tsantes A. Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia. 2004;47(6):1071\u20138.","journal-title":"Diabetologia"},{"issue":"6","key":"5846_CR32","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/1055-9965.EPI-12-1046","volume":"22","author":"K Fall","year":"2013","unstructured":"Fall K, Garmo H, Gudbjornsdottir S, Stattin P, Zethelius B. Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden. Cancer Epidemiol Biomark Prev. 2013;22(6):1102\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"11","key":"5846_CR33","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1158\/1055-9965.EPI-06-0410","volume":"15","author":"JS Kasper","year":"2006","unstructured":"Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev. 2006;15(11):2056\u201362.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"5846_CR34","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.urolonc.2012.07.008","volume":"30","author":"BL Pierce","year":"2012","unstructured":"Pierce BL. Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence. Urol Oncol. 2012;30(5):735\u201343.","journal-title":"Urol Oncol"},{"issue":"5","key":"5846_CR35","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00125-016-3884-9","volume":"59","author":"B Carstensen","year":"2016","unstructured":"Carstensen B, Read SH, Friis S, Sund R, Keskimaki I, Svensson AM, Ljung R, Wild SH, Kerssens JJ, Harding JL, et al. Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals. Diabetologia. 2016;59(5):980\u20138.","journal-title":"Diabetologia"},{"issue":"9","key":"5846_CR36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s10552-016-0785-7","volume":"27","author":"C Skriver","year":"2016","unstructured":"Skriver C, Dehlendorff C, Borre M, Brasso K, Sorensen HT, Hallas J, Larsen SB, Tjonneland A, Friis S. Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study. Cancer Causes Control. 2016;27(9):1067\u201379.","journal-title":"Cancer Causes Control"},{"issue":"7","key":"5846_CR37","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/ijc.25186","volume":"127","author":"SM Mahmud","year":"2010","unstructured":"Mahmud SM, Franco EL, Aprikian AG. Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis. Int J Cancer. 2010;127(7):1680\u201391.","journal-title":"Int J Cancer"},{"issue":"7","key":"5846_CR38","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/bjc.2014.381","volume":"111","author":"T Veitonmaki","year":"2014","unstructured":"Veitonmaki T, Murtola TJ, Maattanen L, Taari K, Stenman UH, Tammela TL, Auvinen A. Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial. Br J Cancer. 2014;111(7):1421\u201331.","journal-title":"Br J Cancer"},{"issue":"2","key":"5846_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1398-9995.1997.tb00968.x","volume":"52","author":"AG Oehling","year":"1997","unstructured":"Oehling AG, Akdis CA, Schapowal A, Blaser K, Schmitz M, Simon HU. Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy. 1997;52(2):144\u201354.","journal-title":"Allergy"},{"issue":"15","key":"5846_CR40","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","volume":"74","author":"L Fardet","year":"2014","unstructured":"Fardet L, Feve B. Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events. Drugs. 2014;74(15):1731\u201345.","journal-title":"Drugs"},{"issue":"1","key":"5846_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrurol.2015.254","volume":"13","author":"S Narayanan","year":"2016","unstructured":"Narayanan S, Srinivas S, Feldman D. Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy. Nat Rev Urol. 2016;13(1):47\u201360.","journal-title":"Nat Rev Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5846-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5846-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5846-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T23:04:36Z","timestamp":1592607876000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5846-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5846"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5846-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"assertion":[{"value":"18 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Research Ethics Board, Ume\u00e5 University, Sweden<b>.<\/b> Waiver of informed consent has been granted for Register-based data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"612"}}